🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
This is a multicenter, randomized, double-blinded, positive controlled stud...
Status
Completed
Location
Husada Utama Hospital
Start Date
2024-03-20
Trial ID
NCT06131554
This is a multicenter, randomized, observer-blinded, controlled, immune equ...
Status
Completed
Location
Lingga Health Research Center
Start Date
2020-02-04
Trial ID
NCT04204096
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Unknown
Location
Hunan Center for Disease Control and Prevention
Start Date
2021-12-10
Trial ID
NCT06314685
This study was designed to evaluate the antibody response to a Menactra® bo...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT00777790
This study will be conducted among children in Saudi Arabia who previously ...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00539032
The study investigated safety profile and the antibody responses to an expe...
Status
Completed
Location
Multiple Locations
Start Date
2003-08
Trial ID
NCT00771849
The primary phase of this study is evaluating the safety of Hib-MenCY-TT va...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-09
Trial ID
NCT00345579
This study is a randomized, double-blinded, and controlled phase III clinic...
Status
Unknown
Location
Yunnan Center for Disease Control and Prevention
Start Date
2020-09-15
Trial ID
NCT04689191
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Unknown
Location
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Start Date
2021-09-17
Trial ID
NCT06314659